Damage in cuban patients with systemic lupus erythematosus. Relation with disease features;Daño en pacientes cubanos con lupus eritematoso sistémico. Relación con características de la enfermedad

Reumatologia Clinica

Volumn 6, Issue 1, 2010, Pages 11-15

  Estévez del Toro, Miguel ^a   Chico Capote, Araceli ^a   Hechavarría, Rafael ^a   Jiménez Paneque, Rosa ^a   Kokuina, Elena ^a  

^a HOSPITAL CLINICOQUIRÚRGICO HERMANOS AMEIJEIRAS   (Cuba)

Author keywords

Damage; Systemic lupus erythematosus

Indexed keywords

PREDNISONE;

ADULT; ARTICLE; CLINICAL FEATURE; CUBA; DISEASE COURSE; DRUG OVERDOSE; EYE DISEASE; FEMALE; HUMAN; LEUKOPENIA; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MENTAL DISEASE; MUSCULOSKELETAL DISEASE; RHEUMATOID ARTHRITIS; SKIN DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 73149122340     PISSN: 1699258X     EISSN: 18851398     Source Type: Journal    
DOI: 10.1016/j.reuma.2009.04.007     Document Type: Article

References (47)

1. Bernatzky S., Boivin F., and Joseph L. Mortality in systemic lupus erythematosus. Arthritis Rheum 54 (2006) 2550-2557
2. Mok C.C., Mak A., Chu W.P., To C.H., and Wong S.N. Long-term survival of southern Chinese patients with systemic lupus erythematosus: A prospective study of all age-groups. Medicine (Baltimore) 84 (2005) 218-224
3. Doria A., Iaccarino L., Ghirardello A., Zampieri S., Arienti S., Sarzi- Puttini P., et al. Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med 119 (2006) 700-706
4. Cervera R., Khamashta M.A., and Font J. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: A comparison of early and late manifestation in a cohort of 1000 patients. Medicine 82 (2003) 299-308
5. Gladman D., Ginzler E., Glodsmith C., Fortin P., Liang M., Urowitz M., et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus. Arthritis Rheum 39 (1996) 363-369
6. Goldstein R., and Sengar D.P. Comparative studies of the major histocompatibility complex in French Canadian and non-French Canadian Caucasians with systemic lupus erythematosus. Arthritis Rheum 36 (1993) 1121-1127
7. Gulko P.S., Reveille J.D., Koopman W.J., Burgard S.L., Bartolucci A.A., and Alarcon G.S. Anticardiolipin antibodies in systemic lupus erythematosus: Clinical correlates, HLA associations, and impact on survival. J Rheumatol 20 (1993) 1684-1693
8. Karlson E.W., Daltroy L.H., and Lew R.A. The independence and stability of socioeconomic predictors of morbidity in systemic lupus erythematosus. Arthritis Rheum 38 (1995) 267-273
9. Karlson E.W., Daltroy L.H., and Lew R.A. The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis Rheum 40 (1997) 47-56
10. Liang M.H., Rogers M., and Larson M. The psychosocial impact of systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 27 (1984) 13-19
11. Petri M., Pérez-Gutthann S., Longenecker J.C., and Hochberg M. Morbidity of systemic lupus erythematosus: Role of race and socioeconomic status. Am J Med 91 (1991) 345-353
12. Reveille J.D., Bartolucci A., and Alarcón G.S. Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. Arthritis Rheum 33 (1990) 37-48
13. Studenski S., Allen N.B., Caldwell D.S., Rice J.R., and Polisson R.P. Survival in systemic lupus erythematosus. A multivariate analysis of demographic factors. Arthritis Rheum 30 (1987) 1326-1332
14. Serdula M.K., and Rhoads G.G. Frequency of systemic lupus erythematosus in different ethnic groups in Hawaii. Arthritis Rheum 22 (1979) 328-333
15. Walsh S.J., Algert C., Gregorio D.I., Reisine S.T., and Roth N.F. Divergent racial trends in mortality from systemic lupus erythematosus. J Rheumatol 22 (1995) 1663-1668
16. Sutcliffe N., Clarke A.E., Gordon C., Farewell V., and Isenberg D.A. The association of socio-economic status, race, psychosocial factors and outcome in patients with systemic lupus erythematosus. Rheumatology (Oxford) 38 (1999) 1130-1137
17. Calvo-Alén J., Reveille J.D., Rodríguez Valverde V., McGwin G., Baethge B.A., Friedman A.W., et al. Clinical, immunogenetic and outcome features of Hispanic systemic lupus erythematosus patients of different ethnic ancestry. Lupus 12 (2003) 377-385
18. Stoll T., Seifert B., and Isenberg D.A. SLICC/ACR Damage Index is valid and renal and pulmonary organ scores are predictors of severe outcome in patients with systemic lupus erythematosus. Br J Rheumatol 35 (1996) 248-254
19. Rahman P., Gladman D.D., Urowitz M.B., Hallett D., and Tam L.S. Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus. Lupus 10 (2001) 93-96
20. Gladman D.D., Goldsmith C.H., and Urowitz M.B. The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ ACR) Damage Index for systemic lupus international comparison. J Rheumatol 27 (2000) 373-376
21. Tan E.M., Cohen A.S., and Fries J.F. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25 (1982) 1271-1277
22. Alarcón G.S., McGwin Jr. G., and Bastian H.M. Systemic lupus erythematosus in the three ethnic groups: VII. Predictors of early mortality in the LUMINA cohort. Arthritis Care Res 45 (2001) 191-202
23. Pineau C.A., Bernatsky S., Abrahamowicz M., Neville C., Karp I., and Clarke A.E. A comparison of damage accrual across different calendar periods in systemic lupus erythematosus patients. Lupus 15 (2006) 390-394
24. Sung Y.K., Hur N.W., Sinskey J.L., Park D., and Bae S.C. Assessment of damage in Korean patients with systemic lupus erythematosus. J Rheumatol 34 (2007) 987-991
25. Yee C.S., Hussein H., Skan J., Bowman S., Situnayake D., and Gordon C. Association of damage with autoantibody profile, age, race, sex, and disease duration in systemic lupus erythematosus. Rheumatology 42 (2003) 276-279
26. Becker-Merok A., and Nossent H.C. Damage accumulation in systemic lupus erythematosus and its relation to disease activity and mortality. J Rheumatol 33 (2006) 1570-1577
27. Rivest C., Lew R.A., Welsing P.M., Sangha O., Wright E.A., Roberts W.N., et al. Association between clinical factors, socioeconomic status and organ damage in recent onset systemic lupus erythematosus. J Rheumatol 27 (2000) 680-684
28. Guarize J., Appenzeller S., and Costallat L.T. Skin damage occurs early in systemic lupus erythematosus and independently of disease duration in Brazilian patients. Rheumatol Int 27 (2007) 483-487
29. Zonana-Nacach A., Camargo-Coronel A., and Yáñez P. Measurement of damage in 210 Mexican patients with systemic lupus erythematosus: Relationship with disease duration. Lupus 7 (1988) 119-123
30. Brunner H.I., Silverman E.D., To T., Bombardier C., and Feldman B.M. Risk factors for damage in chiildhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predicts disease damage. Arthritis Rheum 46 (2002) 436-444
31. Gladman D.D., Urowitz M.B., Rahman P., Ibáñez D., and Tan L.S. Accrual of organ damage over time in patients with systemic lupus erythematosus. J Rheumatol 30 (2003) 1955-1959
32. Maddison P., Farewell V., and Iseberg D. The rate and pattern of organ damage in late onset systemic lupus erythematosus. J Rheumatol 29 (2002) 913-917
33. Thumboo, Fong K.-Y., and Chan S.-P. A prospective study of factors affecting quality of life in systemic lupus erythematosus. J Rheumatol 27 (2000) 1414-1420
34. Santana M.V.S., Minami C.S.H., Ramalho R.M.M., Szajubok J.C.M., Araujo N.C., and Chahade W.H. Aspectos clínicos de pacientes com lupicos com duraçao de doença maior que dez anos: Avaliaçao preliminary. Rev Bras Reumatol 42 (2002) S87 (abstrac175)
35. Sella E.M.C., Silava E.A., and Sato E.I. Avaliação do índice de danos permanentes pelo Systemic Lupus International Collaborating Clinics/American Collegue of Rheumatology Damage Index for systemic lupus erythematosus 112 pacientes. Rev Bras Reumatol 42 (2002) S89
36. Soares M., Reis L., Papi J.A.S., and Cardoso C.R.L. Rate, pattern and factors related do damage in Brazilian systemic lupus erythematosus patients. Lupus 12 (2003) 788-794
37. Cassano G., Roverano S., Paira S., Bellomio V., Lucero E., Berman A., et al. Accrual of organ damage over time in Argentine patients with systemic lupus erythematosus: A multi- centre study. Clin Rheumatol 26 (2007) 2017-2022
38. Watson R. Cutaneous lesions in systemic lupus erythematosus. Med Clin North Am 73 (1989) 1091-1111
39. Bezerra M.C., Saraiva M.C., Borba E.F., Gonçalves C.R., and Bonfa E. Dano precoce no lupus eritematoso sistemico-associado a atividade de doença ou a terapeutica?. Rev Bras Reumatol 42 (2002) S103
40. Mody G.M., Parag K.B., Nathoo B.C., Pudifin D.J., Duursma J., and Sedat Y.K. High mortality with systemic lupus eythematosus in hospitalised African blacks. Br J Rheumatol 33 (1994) 1151-1153
41. Nived O., Josent A., Bengtsson A.A., Bengtsson C., and Sturfelt G. High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for survival in systemic lupus erythematosus. J Rheumatol 29 (2002) 1398-1400
42. To C.H., and Petri M. Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus?. Arthritis Rheum 52 (2005) 4003-4010
43. Mikdashi J., Krumholz A., and Handwerger B. Factors at diagnosis predict subsequent occurrence of seizures in systemic lupus erythematosus. Neurology 64 (2005) 2102-2107
44. Zonana Nacach A., Barr S.G., Magder L.S., and Petri M. Damage in systemic lupus erythematosus and its association with corticosteroids. Arthritis Rheum 45 (2000) 1801-1808
45. Alarcón G.S., McGwin J.R., Bartolucci A.A., Roseman J., Lisse J., Fresler B.J., et al. Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual. Arthritis Rheum 44 (2001) 2797-2806
46. Petri M. Hydroxychloroquine prevents later damage in SLE. Arthritis Rheum 44 (2001) S247
47. Molad Y., Gorshtein A., and Wysenbeek A.J. Protective effect of hydroxychloroquinein in systemic lupus erythematosus. Prospective long-term study of an Israeli cohort. Lupus 11 (2002) 356-361